Veterinary Medicines

OXYMYCIN AEROSSOL 32,1 mg/ml Solução para pulverização cutânea para bovinos e ovinos

Authorised
  • Oxytetracycline
Download as PDF

Product identification

Medicine name:
OXYMYCIN AEROSSOL 32,1 mg/ml Solução para pulverização cutânea para bovinos e ovinos
Active substance:
  • Oxytetracycline
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Oxytetracycline
    37.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Cutaneous spray, suspension
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD06AX99
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Available in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 51567
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 25/09/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."